Osimertinib Treatment on EGFR T790M Plasma Positive NSCLC Patients (APPLE)
Clinical trial NCT02856893 · COMPLETED
Trial details
- NCT number
- NCT02856893
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-10
- Primary completion
- 2022-09-20
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.